Find information on thousands of medical conditions and prescription drugs.

Vivelle

The estrogen patch is a delivery system for estradiol used as hormone replacement therapy to treat the symptoms of menopause, such as hot flashes and vaginal dryness, and to prevent osteoporosis. Originally marketed as VivelleĀ® (Novartis), it was discontinued in 2003 and reintroduced in a smaller form as Vivelle-DotĀ®. Although the estrogen is given transdermally rather than in the standard oral tablets, the estrogen patch carries similar risks and benefits as more conventional forms of estrogen-only hormone replacement therapy.

Administration

Applied to the skin (not breasts) twice weekly.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Hydrocodone
Vagifem
Valaciclovir
Valcyte
Valganciclovir
Valine
Valium
Valnoctamide
Valproate semisodium
Valproic acid
Valpromide
Valrelease
Valsartan
Valstar
Valtrex
Vancenase
Vanceril
Vancomycin
Vaniqa
Vanticon
Vecuronium bromide
Velcade
Velivet
Venlafaxine
Ventolin
Vepesid
Verapamil
Verelan
Vermox
Versed
Vfend
Viadur
Viagra
Vicoprofen
Vidarabine
Vidaza
Videx
Vigabatrin
Viloxazine
Vinblastine
Vincristine
Vinorelbine
Viomycin
Vioxx
Viracept
Viread
Visine
Vistide
Visudyne
Vitaped
Vitrase
Vivelle
Volmax
Voltaren
Voriconazole
Vosol
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Estrogen Patch
From OB/GYN News, 9/1/01

Vivelle (estradiol transdermal system), an estrogen replacement patch applied twice weekly, is now available in a 0.025-mg daily dose. Designed to prevent loss of bone density, the Vivelle patch is available in four other dosage strengths: 0.0375, 0.05, 0.075, and 0.1 mg/day.

COPYRIGHT 2001 International Medical News Group
COPYRIGHT 2001 Gale Group

Return to Vivelle
Home Contact Resources Exchange Links ebay